Drugs / GSK4347859
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06188507 | Jan 2024 → Jul 2026 | systemic lupus erythematosus | GlaxoSmithKline | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK4347859 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06188507 ↗ |